ENHANCEMENT OF THE DNA BREAKAGE AND CYTO-TOXIC EFFECTS OF INTERCALATING AGENTS BY TREATMENT WITH SUBLETHAL DOSES OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE OR HYDROXYUREA IN L1210 CELLS

被引：0

作者：

MINFORD, J

KERRIGAN, D

NICHOLS, M

SHACKNEY, S

ZWELLING, LA

机构：

[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,MOLEC PHARMACOL LAB,BLDG 37,ROOM 5A19,BETHESDA,MD 20205

[2] NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205

来源：

CANCER RESEARCH | 1984年 / 44卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5583 / 5593

页数：11

共 50 条

[31] CYTOKINETIC STUDY ON THE EFFECTS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE ON MURINE LEUKEMIC-CELLS L-1210 - A COMPARISON WITH THE EFFECTS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE
MARUO, N
HORIUCHI, H
NAKABO, T
KONDO, M
NAKAMURA, T
HEMATOLOGICAL ONCOLOGY, 1985, 3 (01) : 39 - 48
[32] SEQUENCE-DEPENDENT ANTITUMOR EFFECT OF VP-16 AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN L1210 ASCITES TUMOR
OHKUBO, T
HIGASHIGAWA, M
KAWASAKI, H
KAMIYA, H
SAKURAI, M
KAGAWA, Y
KAKITO, E
SUMIDA, K
OOI, K
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1823 - 1828
[33] SEQUENTIAL CHEMOTHERAPY WITH CYTOXAN AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE (ARA-C) IN MICE WITH ADVANCED LEUKEMIA L1210
HOFFMAN, GS
WARAVDEK.VS
VENDITTI, JM
MANTEL, N
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1968, 9 (MAR): : 31 - &
[34] BIOCHEMICAL AND GENETIC STUDIES OF A MUTANT STRAIN OF MOUSE LEUKEMIA L1210 RESISTANT TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE (CYTARABINE) HYDROCHLORIDE
BACH, MK
CANCER RESEARCH, 1969, 29 (05) : 1036 - +
[35] EFFECT OF METHOTREXATE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE ON POOLS OF DEOXYRIBONUCLEOSIDE TRIPHOSPHATES IN L1210-ASCITES-CELLS
ROBERTS, D
PECK, C
CANCER RESEARCH, 1981, 41 (02) : 505 - 510
[36] SEDIMENTATION OF DNA FROM L1210 CELLS AFTER TREATMENT WITH 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-2-THENYLIDENE-BETA-D-GLUCOPYRANOSIDE) OR 1-BETA-D-ARABINOFURANOSYLCYTOSINE OR BOTH DRUGS
ROBERTS, D
HILLIARD, S
PECK, C
CANCER RESEARCH, 1980, 40 (11) : 4225 - 4231
[37] ENHANCEMENT OF CA2+-DEPENDENT ENDONUCLEASE ACTIVITY IN L1210 CELLS DURING APOPTOSIS INDUCED BY 1-BETA-D-ARABINOFURANOSYLCYTOSINE - POSSIBLE INVOLVEMENT OF ACTIVATING FACTOR(S)
TAKAUJI, R
YOSHIDA, A
IWASAKI, H
TOYAMA, K
UEDA, T
NAKAMURA, T
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (07): : 677 - 684
[38] CHEMOTHERAPY OF LEUKEMIA L1210 IN MICE WITH 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE .2. EFFECTIVENESS AGAINST INTRACEREBRALLY AND SUBCUTANEOUSLY INOCULATED LEUKEMIC CELLS
KLINE, I
VENDITTI, JM
TYRER, DD
MANTEL, N
GOLDIN, A
CANCER RESEARCH, 1966, 26 (9P1) : 1930 - +
[39] COMBINED CHRONOCHEMOTHERAPY OF L1210 LEUKEMIC MICE USING 1-BETA-D-ARABINOFURANOSYLCYTOSINE, CYCLOPHOSPHAMIDE, VINCRISTINE, METHYLPREDNISOLONE AND CIS-DIAMMINEDICHLOROPLATINUM
SCHEVING, LE
BURNS, ER
HALBERG, F
PAULY, JE
CHRONOBIOLOGIA, 1980, 7 (01) : 33 - 40
[40] MODULATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) BY N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) AND ACIVICIN (AC) IN L1210 CELLS
RIVA, CM
MARQUET, J
SUBERVILLE, AM
ZITTOUN, J
ZITTOUN, R
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 301 - 301

← 1 2 3 4 5 →